Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update
LYMPHIR commercial availability planned for the fourth quarter of 2025 $12.5 million in gross financings raised during the quarter by...
LYMPHIR commercial availability planned for the fourth quarter of 2025 $12.5 million in gross financings raised during the quarter by...
$12.5 million in gross financings raised during the quarter, with an additional $9 million raised by Citius Oncology in July...
LYMPHIR commercial availability planned for the fourth quarter of 2025 $12.5 million in gross financings raised during the quarter by...
RIO DE JANEIRO, Aug. 12, 2025 /PRNewswire/ -- Vinci Compass Investments Ltd. (NASDAQ: VINP) ("Vinci Compass," "the Company," "we," "us,"...
On track to submit Biologics License Application (BLA) for INO-3107 in 2H25, with the goal of file acceptance by year...
Toronto, Ontario--(Newsfile Corp. - August 12, 2025) - Black Swan Graphene Inc. (TSXV: SWAN) (OTCQX: BSWGF) (FSE: R960) ("Black Swan" or...
BERKELEY, Calif.--(BUSINESS WIRE)--Bolt Projects Holdings, Inc. (Nasdaq: BSLK), a developer of biomaterials for the beauty and personal care industry, reported...
Delivered Revenue and Adjusted EBITDA above the top end of Guidance Ranges Second Quarter Revenue Growth of 8.5%; Revenue Growth...
Entered into secured credit agreement with Innoviva for $15 million maturing in 2029 Announced positive topline results from the Phase...
Additional members to join the Advisory Committee in the coming weeks to optimize performance, increase visibility and unlock capital raising...
Net proceeds from the Offering to be used for exploring the accumulation of cryptocurrencies and crypto mining equipment, working capital...
Improved Adjusted EBITDA: Substantially narrowed Adjusted EBITDA loss by $2 million for the six-month period.Operating Expense Reduction: Reduced operating expenses...
2Q 2025 revenue of $85.8 million 2Q 2025 net income of $21.4 million which includes a $(21.7) million tax benefit...
– Fathom achieved 36% year-over-year revenue growth, driven by 25% transaction growth –CARY, N.C., Aug. 12, 2025 /PRNewswire/ -- Fathom...
Improved Adjusted EBITDA: Substantially narrowed Adjusted EBITDA loss by $2 million for the six-month period.Operating Expense Reduction: Reduced operating expenses...
MINNETONKA, Minn., Aug. 12, 2025 /PRNewswire/ -- Electro-Sensors, Inc. (NASDAQ: ELSE), a leading global provider of machine monitoring sensors and...
- Cognition and FDA align on enriched population, study design, and endpoints - PURCHASE, N.Y., Aug. 12, 2025 (GLOBE NEWSWIRE)...
SINGAPORE, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Bit Origin Ltd (NASDAQ: BTOG) ("Bit Origin" or the "Company"), today announced the...
VANCOUVER, BC, Aug. 12, 2025 /PRNewswire/ - Aris Mining Corporation ("Aris Mining" or the "Company") (TSX: ARIS) (NYSE-A: ARMN) is...
VANCOUVER, BC, Aug. 12, 2025 /PRNewswire/ -- As the global economy undergoes profound restructuring, fintech continues to evolve, and cross-border...
LIVERMORE, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven company in the fuel...
Topline data from SERENITY At-Home Phase 3 trial for acute treatment of agitation associated with bipolar disorders or schizophrenia expected in August...
HAUPPAUGE, N.Y., Aug. 12, 2025 (GLOBE NEWSWIRE) -- AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art...
Kefir market leader posts $53.9 million in net sales, an 18% volume-led net sales increase on a comparable basis, marking nearly...
WESTBOROUGH, Mass.--(BUSINESS WIRE)--Kopin Corporation (“Kopin” or “the Company”) (Nasdaq: KOPN), a leading developer and provider of high-performance application-specific optical solutions...
FDA Provides Positive Feedback, Clears Path for Atossa to File IND for (Z)-Endoxifen in Metastatic Breast Cancer; FDA Indicates No...
Former Luminar Optical Engineering Executive to Spearhead LightPath's Transition from Component to System Supplier ORLANDO, Fla., Aug. 12, 2025 /PRNewswire/...
- 10-hour runtime and true hands-free operation set new performance standard for full-shift warehouse usage ROCHESTER, N.Y., Aug. 12, 2025 /PRNewswire/...
The 90-second commercial builds on the "Bent Carrot" campaign, launched in 2021, with creative that highlights a couple's journey from...
LAS VEGAS, Aug. 12, 2025 /PRNewswire/ -- Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging technology company developing...
Newly issued patent extends protection of proprietary solid tumor CAR-T platform to 2045 SAN JOSE, Calif., Aug. 12, 2025 /PRNewswire/...
WOOD DALE, Ill., Aug. 12, 2025 /PRNewswire/ -- AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial...
DULUTH, Ga., Aug. 12, 2025 /PRNewswire/ -- AGCO (NYSE: AGCO), a global leader in the design, manufacture and distribution of...
NEW YORK, Aug. 12, 2025 /PRNewswire/ -- IQSTEL Inc. (NASDAQ: IQST) today announced preliminary July 2025 revenue of approximately $35 million,...
IMC Delivers Strong Profit and Margin Growth Despite Revenue Impact from External Challenges in Q2 2025 TORONTO and GLIL YAM,...
- Revenue of $1.9 Million consistent with the year-ago period- Revenue led by Population Health's growth up 197% compared to...
HOUSTON, Aug. 12, 2025 /PRNewswire/ -- Summit Midstream Corporation (NYSE: SMC) ("Summit", "SMC" or the "Company") announced today its financial...
U.S. Patent No. 12379378-B2 protects biomarker-driven systems and methods to assess progression risk in Barrett’s esophagus and esophageal adenocarcinoma; issuance...
Enrollment ongoing in Phase 2 KOURAGE trial of Auxora™ in acute kidney injury (AKI) with respiratory failure; data expected in...
Fourth quarter revenue was relatively flat at $60.2 billion; revenue increased 21% excluding the impact of a previously communicated contract...